| Ronald S Lederman, MD | |
|
2300 Haggerty Rd, Suite 1110, West Bloomfield, MI 48323-2184 | |
| (248) 669-2000 | |
| (248) 669-2110 |
| Full Name | Ronald S Lederman |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 2300 Haggerty Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609855253 | NPI | - | NPPES |
| P00215896 | Other | MEDICARE RAILROAD | |
| F72414 | Other | HAP | |
| 0F33953 | Other | MI | BCBS |
| 203208200 | Other | WORK COMP | |
| 129392 | Other | CARE CHOICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | RL064514 (Michigan) | Primary |
| 174400000X | Specialist | RL064514 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ronald S Lederman Md Pllc | 8224115563 | 10 |
News Archive
An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which reviews the evidence of bone turnover markers (BTMs) in fracture risk prediction and monitoring of osteoporosis therapy. More importantly, it identifies research priorities and recommends that specific markers be used as reference analytes for BTMs in clinical and observational studies.
Among the problems people with Autism spectrum disorders (ASD) struggle with are difficulties with social behavior and communication. That can translate to an inability to make friends, engage in routine conversations, or pick up on the social cues that are second nature to most people. Similarly, in a mouse model of ASD, the animals, like humans, show little interest in interacting or socializing with other mice.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program.
› Verified 8 days ago
| Entity Name | Ronald S Lederman Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003964610 PECOS PAC ID: 8224115563 Enrollment ID: O20080410000326 |
News Archive
An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which reviews the evidence of bone turnover markers (BTMs) in fracture risk prediction and monitoring of osteoporosis therapy. More importantly, it identifies research priorities and recommends that specific markers be used as reference analytes for BTMs in clinical and observational studies.
Among the problems people with Autism spectrum disorders (ASD) struggle with are difficulties with social behavior and communication. That can translate to an inability to make friends, engage in routine conversations, or pick up on the social cues that are second nature to most people. Similarly, in a mouse model of ASD, the animals, like humans, show little interest in interacting or socializing with other mice.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald S Lederman, MD Po Box 74008434, Chicago, IL 60674-8434 Ph: (248) 669-2000 | Ronald S Lederman, MD 2300 Haggerty Rd, Suite 1110, West Bloomfield, MI 48323-2184 Ph: (248) 669-2000 |
News Archive
An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which reviews the evidence of bone turnover markers (BTMs) in fracture risk prediction and monitoring of osteoporosis therapy. More importantly, it identifies research priorities and recommends that specific markers be used as reference analytes for BTMs in clinical and observational studies.
Among the problems people with Autism spectrum disorders (ASD) struggle with are difficulties with social behavior and communication. That can translate to an inability to make friends, engage in routine conversations, or pick up on the social cues that are second nature to most people. Similarly, in a mouse model of ASD, the animals, like humans, show little interest in interacting or socializing with other mice.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program.
› Verified 8 days ago
Dr. Collin James Okeefe, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 Haggerty Rd, Suite 1110, West Bloomfield, MI 48323 Phone: 248-669-2000 Fax: 248-669-2110 | |
David A. Katcherian, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6777 W Maple Rd, West Bloomfield, MI 48322 Phone: 248-661-6471 Fax: 248-661-7155 | |
Dr. Robb Matthew Weir, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6777 W Maple Rd, West Bloomfield, MI 48322 Phone: 248-661-6408 Fax: 248-661-7155 | |
Dr. Christopher Lee Cooke, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6525 W Maple Rd, Suite 101e, West Bloomfield, MI 48322 Phone: 248-489-4410 Fax: 248-489-4420 | |
Stephen Patrick Desilva, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6777 W Maple Rd, West Bloomfield, MI 48322 Phone: 248-661-6470 | |
Dr. Bruce D Abrams, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4100 Shore Crest Dr, West Bloomfield, MI 48323 Phone: 248-932-4006 |